Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

132
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
132
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

110
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
110
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

108
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
108
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

73
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
73
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

107
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
107
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

92
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
92

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-Wide Identification and Expression Analysis of the Soybean <i>GmHSP100</i> Gene Family in Response to Heat and Salt Stresses.

Genes·2026
Same author

Anion-induced dynamic built-in electric field enables directional migration of lithium polysulfides and bidirectional catalysis.

Journal of colloid and interface science·2026
Same author

ANXA11 suppression restores muscular function in the mdx mouse model of Duchenne muscular dystrophy (DMD).

Nature communications·2026
Same author

CRLF1 Secreted by Cardiac Fibroblasts Promotes Human Hypertrophic Cardiomyopathy.

Circulation·2026
Same author

Mapping the global research landscape on HPV vaccine hesitancy: a machine-learning based bibliometric analysis.

Virology journal·2026
Same author

A dual-functional CoF₂@C-coated separator toward synergistic suppression of polysulfide shuttle and Lithium dendrite growth for stable Lithium-sulfur batteries.

Journal of colloid and interface science·2026
Same journal

A computer-aided diagnosis tool in prostate cancer patients with biochemical recurrence using 18F-PSMA PET/CT imaging.

Medical physics·2026
Same journal

Investigating the uncertainty of cellular microenvironment parameter estimations via diffusion MRI cytometry.

Medical physics·2026
Same journal

Correction to "On the shape of the radiation survival curve in tumor spheroids: The role of oxygen heterogeneity".

Medical physics·2026
Same journal

Multi-view constrained semi-supervised vertebra detection for 3D ultrasound spine volume.

Medical physics·2026
Same journal

Accuracy of quantitative <sup>177</sup>Lu SPECT/CT imaging: A systematic review.

Medical physics·2026
Same journal

Physics-constrained dual-domain network for CBCT reconstruction from orthogonal X-rays in gynecologic radiotherapy.

Medical physics·2026
See all related articles

Related Experiment Video

Updated: Dec 5, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.8K

Simultaneous dose and dose rate optimization (SDDRO) for FLASH proton therapy.

Hao Gao1, Bowen Lin1,2, Yuting Lin1

  • 1Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.

Medical Physics
|October 17, 2020
PubMed
Summary
This summary is machine-generated.

FLASH proton radiotherapy (RT) utilizes ultra-high dose rates for normal tissue sparing. A new simultaneous dose and dose rate optimization (SDDRO) method significantly improves dose rate distribution for better treatment outcomes.

Keywords:
FLASHIMPTdose rate optimizationproton therapy

More Related Videos

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.0K
Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator
07:31

Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator

Published on: May 9, 2014

12.1K

Related Experiment Videos

Last Updated: Dec 5, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.8K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.0K
Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator
07:31

Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator

Published on: May 9, 2014

12.1K

Area of Science:

  • Radiation Oncology
  • Medical Physics
  • Computational Biology

Background:

  • FLASH radiotherapy (RT) aims to reduce normal tissue toxicity by using ultra-high dose rates (≥40 Gy/s).
  • Current proton RT treatment planning optimizes dose distribution but not dose rate, limiting FLASH's potential.
  • Proton RT is a viable modality for achieving the high dose rates required for FLASH techniques.

Purpose of the Study:

  • To develop a novel treatment optimization method for FLASH proton RT that optimizes both dose and dose rate distributions simultaneously.
  • To introduce Simultaneous Dose and Dose Rate Optimization (SDDRO) to enhance the therapeutic ratio in FLASH proton therapy.
  • To address the limitation of existing methods that only optimize dose distribution, not dose rate.

Main Methods:

  • SDDRO is formulated as a constrained optimization problem incorporating dose-volume constraints and minimum dose rate constraints.
  • The optimization algorithm employs iterative convex relaxation and the alternating direction method of multipliers.
  • Algorithms were developed for both constant and variable beam intensity scenarios.

Main Results:

  • SDDRO significantly improved dose rate distribution compared to intensity modulated proton therapy (IMPT).
  • The volume of interest receiving ≥40 Gy/s increased from 30-50% to ≥98% with SDDRO.
  • Lung volume receiving ≥40 Gy/s increased from 30-40% to 70-90% with SDDRO.
  • Hypofractionation and multiple beams further enhanced SDDRO plan quality for both dose and dose rate distributions.

Conclusions:

  • A novel joint dose and dose rate optimization method, SDDRO, was developed for FLASH proton RT.
  • SDDRO substantially improves FLASH dose rate coverage, enhancing normal tissue sparing while preserving dose distribution.
  • Combining hypofractionation and multiple beams can further optimize SDDRO plan quality.